ipsc technology still has a cloud of doubt on it with safety and we only just got our first MSC approval after 20 years so it isn't hard to imagine.
Bio is not AI or resources, it needs to be proven over long duration, and then approved by the FDA.
Unfortunately the only change to CYP will be a decimal place to the left.
- Forums
- ASX - By Stock
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

ipsc technology still has a cloud of doubt on it with safety and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $42.36K | 259.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19056 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 43246 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19056 | 0.170 |
2 | 91273 | 0.165 |
5 | 695374 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 43246 | 4 |
0.180 | 173524 | 8 |
0.185 | 58190 | 2 |
0.190 | 8868 | 1 |
0.195 | 28488 | 3 |
Last trade - 13.32pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online